Shares of medical technology company Intuitive Surgical (NASDAQ:ISRG) fell 6.2% in the afternoon session after Deutsche Bank cut the stock's rating from Hold to Sell and slashed its price target to $440 from $515, after identifying accelerating competition from lower-cost remanufactured instruments in the Instruments & Accessories segment.
Stay informed about the performance of the S&P500 index in the middle of the day on Monday. Uncover the top gainers and losers in today's session for valuable insights.
Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Monday. Stay informed about the latest market trends.
INTUITIVE SURGICAL INC (NASDAQ:ISRG) shows strong growth fundamentals and a bullish technical pattern, making it a stock to watch. High profitability, solid financial health, and a favorable price setup suggest potential upside.
Chipmaker Nvidia Corp. (NASDAQ: NVDA) may have carved out a lead for itself in AI that is nearly impossible to dislodge, according to a former Advanced Micro Devices Inc. (NASDAQ: AMD) engineer, who believes that the latter might still have an upper hand across a few niche areas.
A company with profits isn’t always a great investment.
Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Intuitive Surgical (NASDAQ:ISRG) and the rest of the surgical equipment & consumables - specialty stocks fared in Q1.
The Nasdaq 100 (^NDX) is packed with high-growth companies, and while the market is competitive, some are pulling ahead.
A handful of standout businesses are continuing to scale, delivering strong financials and market leadership.
Intuitive Surgical Inc. (NASDAQ: ISRG) announces Dave Rosa as next CEO, effective July 1, 2025. Long-serving CEO Gary Guthart to become executive chair.
